Ogata Y, Yamauchi M, Kim R H, Li J J, Freedman L P, Sodek J
Medical Research Council Group in Periodontal Physiology, Faculty of Dentistry, University of Toronto, Canada.
Eur J Biochem. 1995 May 15;230(1):183-92. doi: 10.1111/j.1432-1033.1995.0183i.x.
Glucocorticoids modulate the development and growth of many organs through interactions with a specific intracellular receptor (glucocorticoid receptor) that regulates gene transcription through a cognate element, the glucocorticoid response element (GRE), in the promoter of target genes. In bone formation glucocorticoids stimulate osteoblast differentiation and the formation of bone matrix. Recent studies have demonstrated that the induction of the bone sialoprotein (BSP) gene is associated with osteoblast differentiation and de novo bone formation. To determine the molecular pathways of glucocorticoid regulation of BSP expression, we have analyzed the effects of the synthetic glucocorticoid, dexamethasone, on the expression of the BSP by bone cells in vitro. At 10 nM, dexamethasone induced BSP expression in association with bone tissue formation by confluent fetal rat calvarial cells and adult rat marrow cells and also stimulated BSP expression up to sixfold in osteoblastic cells (UMR 106-6 and ROS 17/2.8 cells). Most of the stimulation was blocked by cycloheximide, indicating direct and indirect mechanisms of BSP gene regulation. Nuclear 'run-on' transcription analysis revealed an up to twofold increase in transcription corresponding to the increase in mRNA that was unaffected by cycloheximide. Analysis of BSP mRNA in the presence of a transcription inhibitor (5,6-dichloro-1-beta-D-ribofuanosyl benzimidazole) by Northern hybridization revealed that the stability of the BSP mRNA was not significantly altered by dexamethasone, indicating that the major, indirect, stimulation of BSP expression involves a nuclear post-transcriptional mechanism. To study the direct effects of dexamethasone, nucleotide sequence analysis of the rat BSP promoter was extended upstream to position -2992 and downstream to +2282 in the first intron. Transient transfection analyses, using various rat BSP promoter constructs linked to a luciferase reporter gene, and gel mobility shift assays were used to identify a putative glucocorticoid response unit comprising three GRE half-sites and a putative AP-1 site, located within positions -906 to -931 upstream from the translation start site of the BSP gene promoter. BSP transcription was stimulated approximately 1.5-fold by dexamethasone through this GRE, indicating that its direct effects are mediated by glucocorticoid receptor binding to this site. These studies, therefore, have identified both indirect and direct pathways of glucocorticoid regulation of BSP gene expression, the direct effects being mediated by a GRE in the rat BSP promoter through which the effects of glucocorticoids on BSP gene transcription appear to be regulated.
糖皮质激素通过与特定的细胞内受体(糖皮质激素受体)相互作用来调节许多器官的发育和生长,该受体通过靶基因启动子中的同源元件——糖皮质激素反应元件(GRE)来调节基因转录。在骨形成过程中,糖皮质激素刺激成骨细胞分化和骨基质形成。最近的研究表明,骨唾液酸蛋白(BSP)基因的诱导与成骨细胞分化和新生骨形成有关。为了确定糖皮质激素调节BSP表达的分子途径,我们分析了合成糖皮质激素地塞米松对体外骨细胞中BSP表达的影响。在10 nM时,地塞米松诱导汇合的胎鼠颅骨细胞和成年大鼠骨髓细胞表达BSP并形成骨组织,同时也使成骨细胞(UMR 106-6和ROS 17/2.8细胞)中的BSP表达增加高达6倍。大部分刺激被放线菌酮阻断,表明BSP基因调节存在直接和间接机制。核“连续”转录分析显示,转录增加高达两倍,这与不受放线菌酮影响的mRNA增加相对应。通过Northern杂交分析在存在转录抑制剂(5,6-二氯-1-β-D-核糖基苯并咪唑)的情况下BSP mRNA,结果表明地塞米松并未显著改变BSP mRNA的稳定性,这表明对BSP表达的主要间接刺激涉及核转录后机制。为了研究地塞米松的直接作用,将大鼠BSP启动子的核苷酸序列分析延伸至上游-2992位和第一内含子下游+2282位。使用与荧光素酶报告基因连接的各种大鼠BSP启动子构建体进行瞬时转染分析,并通过凝胶迁移率变动分析来鉴定一个假定的糖皮质激素反应单元,该单元由三个GRE半位点和一个假定的AP-1位点组成,位于BSP基因启动子翻译起始位点上游-906至-931位之间。地塞米松通过这个GRE刺激BSP转录约1.5倍,表明其直接作用是由糖皮质激素受体与该位点结合介导的。因此,这些研究确定了糖皮质激素调节BSP基因表达的间接和直接途径,直接作用由大鼠BSP启动子中的一个GRE介导,糖皮质激素对BSP基因转录的影响似乎通过该GRE来调节。